This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Aug 26;356(9231):768.

doi: 10.1016/S0140-6736(05)73668-0.

Long-term inhibition of platelet aggregation

V Kolesnik, A Biskop

PMID: 11085714
DOI: 10.1016/S0140-6736(05)73668-0

Comment

Long-term inhibition of platelet aggregation

V Kolesnik et al. Lancet. 2000.

. 2000 Aug 26;356(9231):768.

doi: 10.1016/S0140-6736(05)73668-0.

Authors

V Kolesnik, A Biskop

PMID: 11085714
DOI: 10.1016/S0140-6736(05)73668-0

No abstract available

PubMed Disclaimer

Comment on

Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes.
[No authors listed] [No authors listed] Lancet. 2000 Jan 29;355(9201):337-45. Lancet. 2000. PMID: 10665552 Clinical Trial.
Platelets.
George JN. George JN. Lancet. 2000 Apr 29;355(9214):1531-9. doi: 10.1016/S0140-6736(00)02175-9. Lancet. 2000. PMID: 10801186 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.